Undertaking. During the term of this Agreement, each Party (the “Receiving Party”) shall keep confidential, and other than as provided herein shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, disclosed to the Receiving Party by the other Party (the “Proprietary Party”), whether in tangible or intangible form, the confidentiality of which such Proprietary Party takes reasonable measures to protect, including but not limited to Collaboration Intellectual Property.
Appears in 4 contracts
Samples: Collaboration and Option Agreement, Collaboration and Option Agreement (Discovery Partners International Inc), Collaboration and Option Agreement (Infinity Pharmaceuticals, Inc.)
Undertaking. During the term of this Agreement, each Party (the “Receiving Party”) party shall keep confidential, and other than as provided herein shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, disclosed to the Receiving Party owned, developed or possessed by the other Party (the “Proprietary Party”)party, whether in tangible or intangible form, the confidentiality of which such Proprietary Party other party takes reasonable measures to protect, including but not limited to Collaboration Intellectual Property.protect (“Confidential Information”). Neither CFFT nor Vertex will use the other party’s Confidential Information except as expressly permitted in this Agreement
Appears in 4 contracts
Samples: Research, Development and Commecialization Agreement (Vertex Pharmaceuticals Inc / Ma), Development and Commecialization Agreement (Royalty Pharma PLC), Development and Commecialization Agreement (Royalty Pharma PLC)
Undertaking. During the term of this Agreement, each Party (the “Receiving Party”) party shall keep confidential, and other than as provided herein herein, shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, disclosed to the Receiving Party owned, developed or possessed by the other Party (the “Proprietary Party”)party, whether in tangible or intangible form, the confidentiality of which such Proprietary Party other party takes reasonable measures to protect, including but not limited to Collaboration Intellectual Property.protect ("Confidential Information"). Neither CFFT nor Predix will use the other party's Confidential Information except as expressly permitted in this Agreement:
Appears in 3 contracts
Samples: Development and Commercialization Agreement (Predix Pharmaceuticals Holdings Inc), Research, Development and Commercialization Agreement (EPIX Pharmaceuticals, Inc.), Development and Commercialization Agreement (Predix Pharmaceuticals Holdings Inc)
Undertaking. During the term of this Agreement, each Party (the “Receiving Party”) party shall keep confidential, and other than as provided herein shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, disclosed to the Receiving Party owned, developed or possessed by the other Party (the “Proprietary Party”)party, whether in tangible or intangible form, the confidentiality of which such Proprietary Party other party takes reasonable measures to protect, including but not limited to Collaboration Intellectual PropertyVERTEX Technology and NOVARTIS Technology.
Appears in 3 contracts
Samples: Research and Early Development Agreement (Vertex Pharmaceuticals Inc / Ma), Confidential Treatment (Vertex Pharmaceuticals Inc / Ma), And Early Development Agreement (Vertex Pharmaceuticals Inc / Ma)
Undertaking. During the term of this Agreement, each Party party (the a “Receiving Party”) shall keep confidential, and other than as provided herein shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, disclosed to the Receiving Party owned, developed or possessed by the other Party party (the “Proprietary Party”), whether in tangible or intangible form, the confidentiality of which such Proprietary Party other party takes reasonable measures to protect, including but not limited to Collaboration Intellectual PropertyTechnology.
Appears in 3 contracts
Samples: Development and Commercialization Agreement (Myogen Inc), License, Development and Commercialization Agreement (Myogen Inc), Development and Commercialization Agreement (Myogen Inc)
Undertaking. During the term of this Agreement, each Party party (the “"Receiving Party”") shall keep confidential, and other than as provided herein shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, disclosed to the Receiving Party owned, developed or possessed by the other Party party (the “"Proprietary Party”"), whether in tangible or intangible form, the confidentiality of which such Proprietary Party takes reasonable measures to protect, including but not limited to Collaboration Intellectual PropertyTechnology.
Appears in 2 contracts
Samples: Collaboration and Option Agreement (Myogen Inc), Collaboration and Option Agreement (Myogen Inc)
Undertaking. During the term of this Agreement, each Party (the “Receiving Party”) shall keep confidential, and other than as provided herein shall not use or disclose, directly or indirectly, any trade secretsInformation owned, confidential developed or proprietary information, or any other knowledge, information, documents or materials, disclosed to the Receiving Party possessed by the other Party (the “Proprietary Party”), whether in tangible or intangible form, the confidentiality of which such Proprietary other Party takes reasonable measures to protect, including but not limited to Collaboration Intellectual PropertyVertex Technology and Avalon Technology.
Appears in 2 contracts
Samples: Commercialization Agreement (Avalon Pharmaceuticals Inc), License, Development and Commercialization Agreement (Avalon Pharmaceuticals Inc)
Undertaking. During the term of this Agreement, each Party party (the “a "Receiving Party”") shall keep confidential, and other than as provided herein shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, disclosed to the Receiving Party owned, developed or possessed by the other Party party (the “"Proprietary Party”"), whether in tangible or intangible form, the confidentiality of which such Proprietary Party other party takes reasonable measures to protect, including but not limited to Collaboration Intellectual PropertyTechnology.
Appears in 2 contracts
Samples: Development and Commercialization Agreement (Myogen Inc), Development and Commercialization Agreement (Myogen Inc)
Undertaking. During the term of this Agreement, each Party (the “Receiving Party”) party shall keep confidential, and other than as provided herein shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, disclosed to the Receiving Party owned, developed or possessed by the other Party (the “Proprietary Party”)party, whether in tangible or intangible form, the confidentiality of which such Proprietary Party other party takes reasonable measures to protect, including but not limited to Collaboration Intellectual Property.protect ("Confidential Information"). Neither CFFT nor Vertex will use the other party's Confidential Information except as expressly permitted in this Agreement
Appears in 1 contract
Samples: Development and Commecialization Agreement (Vertex Pharmaceuticals Inc / Ma)
Undertaking. During the term of this Agreement, each Party (the “Receiving Party”) Each party shall keep confidential, and other than as provided herein herein, shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, disclosed to the Receiving Party owned, developed or possessed by the other Party (the “Proprietary Party”)party, whether in tangible or intangible form, form (“Confidential Information”). All Confidential Information shall be identified as such by the confidentiality of which party disclosing such Proprietary Party takes reasonable measures to protect, including but not limited to Collaboration Intellectual Property.information. Neither CFFT nor CombinatoRx will use the other party’s Confidential Information except as expressly permitted in this Agreement. In addition:
Appears in 1 contract
Samples: Certain Confidential Information (Combinatorx, Inc)
Undertaking. During the term of this Agreement, each Party (the “Receiving Party”) party shall keep confidential, and other than as provided herein shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, disclosed to the Receiving Party owned, developed or possessed by the other Party (the “Proprietary Party”)party, whether in tangible or intangible form, the confidentiality of which such Proprietary Party other party takes reasonable measures to protect, including but not limited to Collaboration Intellectual PropertyVERTEX Kinase Technology and NOVARTIS Kinase Technology.
Appears in 1 contract
Samples: Research and Early Development Agreement (Vertex Pharmaceuticals Inc / Ma)
Undertaking. During the term of this Agreement, each Party (the “Receiving Party”) party shall keep confidential, and other than as provided herein shall not use or disclose, directly or indirectly, any trade secrets, confidential or proprietary information, or any other knowledge, information, documents or materials, disclosed to the Receiving Party owned, developed or possessed by the other Party (the “Proprietary Party”)party, whether in tangible or intangible form, the confidentiality of which such Proprietary Party other party takes reasonable measures to protect, including but not limited to Collaboration Intellectual PropertyVERTEX Know-How and HMR Know-How.
Appears in 1 contract
Samples: License, Development and Commercialization Agreement (Vertex Pharmaceuticals Inc / Ma)
